Revenue: The sum of all revenue fields included for a company's operating activities.
Aclaris Therapeutics, Inc. (ACRS) had Revenue of $1.46M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$1.46M |
$-15.09M |
|
$1.52M |
|
$-0.06M |
|
$19.54M |
|
$-18.08M |
|
$3.00M |
|
$-15.09M |
|
$-15.09M |
|
$-15.09M |
|
$-15.09M |
|
$-15.09M |
|
$-15.09M |
|
$-18.08M |
|
$-17.96M |
|
122.39M |
|
122.39M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$108.79M |
|
$0.94M |
|
$89.30M |
|
$198.09M |
|
$21.51M |
|
-- |
|
$32.51M |
|
$54.03M |
|
$144.07M |
|
$144.07M |
|
$144.07M |
|
108.27M |
|
| Cash Flow Statement Financials | |
$-13.06M |
|
$19.12M |
|
$-0.28M |
|
$24.57M |
|
$30.36M |
|
$5.79M |
|
$3.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.19% |
|
-1242.89% |
|
-1242.89% |
|
-- |
|
-1036.77% |
|
-1036.77% |
|
$-13.10M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
5.82 |
|
15.46 |
|
-10.47% |
|
-10.47% |
|
-7.62% |
|
-10.47% |
|
$1.33 |
|
$-0.11 |
|
$-0.11 |
|